S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NYSE:NHWK

NightHawk Biosciences (NHWK) Stock Price, News & Analysis

$0.44
-0.05 (-10.20%)
(As of 12/29/2023 ET)
Today's Range
$0.44
$0.48
50-Day Range
$0.26
$0.50
52-Week Range
$0.26
$1.29
Volume
192,627 shs
Average Volume
307,237 shs
Market Capitalization
$11.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NHWK stock logo

About NightHawk Biosciences Stock (NYSE:NHWK)

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

NHWK Stock Price History

NHWK Stock News Headlines

FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
NightHawk Biosciences Inc NHWK
NightHawk Biosciences reports Q3 results
FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
NightHawk Biosciences Provides Q3 2023 Business Update
NHWK: 2Q:23 Results
NightHawk Biosciences Provides Q2 2023 Business Update
NHWK: First Scorpius Revenues
NHWK: ANTHIM Sales Boost Revenues
NightHawk Biosciences, Inc. (NHWK)
NHWK: Shifting Focus to Biomanufacturing
See More Headlines
Receive NHWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/20/2023
Today
12/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
77
Year Founded
2008

Profitability

Net Income
$-43,440,000.00
Net Margins
-2,333.27%
Pretax Margin
-2,546.97%

Debt

Sales & Book Value

Annual Sales
$6.38 million
Book Value
$2.82 per share

Miscellaneous

Free Float
21,935,000
Market Cap
$11.48 million
Optionable
Not Optionable
Beta
0.45

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Jeffrey Alan Wolf J.D. (Age 60)
    Founder, Chairman of the Board, CEO & President
    Comp: $842.6k
  • Mr. William L. Ostrander (Age 55)
    CFO & Secretary
    Comp: $476.24k
  • Dr. Ryan D. Michalek Ph.D.
    Senior Vice President of Operations & Strategic Development
  • Dr. Justin Stebbing FRCP
    FRCPath, M.A., M.D., Ph.D., Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
  • Colonel George E. Peoples Jr.
    F.A.C.S., M.D., Chief Medical Advisor














NHWK Stock Analysis - Frequently Asked Questions

Should I buy or sell NightHawk Biosciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NightHawk Biosciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHWK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHWK, but not buy additional shares or sell existing shares.
View NHWK analyst ratings
or view top-rated stocks.

How have NHWK shares performed in 2023?

NightHawk Biosciences' stock was trading at $0.8051 on January 1st, 2023. Since then, NHWK shares have decreased by 45.3% and is now trading at $0.4403.
View the best growth stocks for 2023 here
.

How were NightHawk Biosciences' earnings last quarter?

NightHawk Biosciences, Inc. (NYSE:NHWK) announced its quarterly earnings results on Monday, November, 20th. The biopharmaceutical company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.03. The biopharmaceutical company had revenue of $0.72 million for the quarter, compared to analyst estimates of $1.60 million. NightHawk Biosciences had a negative net margin of 2,333.27% and a negative trailing twelve-month return on equity of 91.62%.

When did NightHawk Biosciences' stock split?

NightHawk Biosciences shares reverse split on the morning of Friday, December 11th 2020. The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

How do I buy shares of NightHawk Biosciences?

Shares of NHWK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NHWK) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -